カテゴリー： QYResearch, 世界

世界の胆嚢癌治療市場 2019年

【英語タイトル】Global Gallbladder Cancer Treatment Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X08283）・商品コード：DATA909X08283
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：113
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、胆嚢癌治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、メシル酸アパチニブ、BGBA-317、ビニメチニブ、その他に、用途別には、クリニック、病院、その他にセグメント区分し、胆嚢癌治療の世界市場を分析しました。


・エグゼクティブ・サマリー
・胆嚢癌治療の世界市場概要
・胆嚢癌治療の製造コスト構成分析
・胆嚢癌治療の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・胆嚢癌治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・胆嚢癌治療のセグメント分析（種類別）
（メシル酸アパチニブ、BGBA-317、ビニメチニブ、その他）
・胆嚢癌治療のセグメント分析（用途別）
（クリニック、病院、その他）
・胆嚢癌治療の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（4SC AG、Advenchen Laboratories LLC、Array BioPharma Inc、Aslan Pharmaceuticals Pte Ltd、Bayer AG、BeiGene Ltd、Eli Lilly and Co、Halozyme Therapeutics Inc、Hutchison MediPharma Ltd、Ipsen SA、Kringle Pharma Inc、Leap Therapeutics Inc、MedImmune LLC、Molecular Templates Inc、Novartis AG、NuCana Plc、OncoTherapy Science Inc、VasGene Therapeutics Inc、）
・胆嚢癌治療の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Gallbladder Cancer Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Gallbladder Cancer Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gallbladder Cancer Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Gallbladder Cancer Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Gallbladder Cancer Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
4SC AG
Advenchen Laboratories LLC
Array BioPharma Inc
Aslan Pharmaceuticals Pte Ltd
Bayer AG
BeiGene Ltd
Eli Lilly and Co
Halozyme Therapeutics Inc
Hutchison MediPharma Ltd
Ipsen SA
Kringle Pharma Inc
Leap Therapeutics Inc
MedImmune LLC
Molecular Templates Inc
Novartis AG
NuCana Plc
OncoTherapy Science Inc
VasGene Therapeutics Inc

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Apatinib Mesylate
BGBA-317
Binimetinib
Others

Segment by Application
Clinic
Hospital
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Gallbladder Cancer Treatment
1.1 Definition of Gallbladder Cancer Treatment
1.2 Gallbladder Cancer Treatment Segment by Type
1.2.1 Global Gallbladder Cancer Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Apatinib Mesylate
1.2.3 BGBA-317
1.2.4 Binimetinib
1.2.5 Others
1.3 Gallbladder Cancer Treatment Segment by Applications
1.3.1 Global Gallbladder Cancer Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Gallbladder Cancer Treatment Overall Market
1.4.1 Global Gallbladder Cancer Treatment Revenue (2014-2025)
1.4.2 Global Gallbladder Cancer Treatment Production (2014-2025)
1.4.3 North America Gallbladder Cancer Treatment Status and Prospect (2014-2025)
1.4.4 Europe Gallbladder Cancer Treatment Status and Prospect (2014-2025)
1.4.5 China Gallbladder Cancer Treatment Status and Prospect (2014-2025)
1.4.6 Japan Gallbladder Cancer Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Gallbladder Cancer Treatment Status and Prospect (2014-2025)
1.4.8 India Gallbladder Cancer Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Gallbladder Cancer Treatment
2.3 Manufacturing Process Analysis of Gallbladder Cancer Treatment
2.4 Industry Chain Structure of Gallbladder Cancer Treatment

3 Development and Manufacturing Plants Analysis of Gallbladder Cancer Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Gallbladder Cancer Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Gallbladder Cancer Treatment
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Gallbladder Cancer Treatment Production and Capacity Analysis
4.2 Gallbladder Cancer Treatment Revenue Analysis
4.3 Gallbladder Cancer Treatment Price Analysis
4.4 Market Concentration Degree

5 Gallbladder Cancer Treatment Regional Market Analysis
5.1 Gallbladder Cancer Treatment Production by Regions
5.1.1 Global Gallbladder Cancer Treatment Production by Regions
5.1.2 Global Gallbladder Cancer Treatment Revenue by Regions
5.2 Gallbladder Cancer Treatment Consumption by Regions
5.3 North America Gallbladder Cancer Treatment Market Analysis
5.3.1 North America Gallbladder Cancer Treatment Production
5.3.2 North America Gallbladder Cancer Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Gallbladder Cancer Treatment Import and Export
5.4 Europe Gallbladder Cancer Treatment Market Analysis
5.4.1 Europe Gallbladder Cancer Treatment Production
5.4.2 Europe Gallbladder Cancer Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Gallbladder Cancer Treatment Import and Export
5.5 China Gallbladder Cancer Treatment Market Analysis
5.5.1 China Gallbladder Cancer Treatment Production
5.5.2 China Gallbladder Cancer Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Gallbladder Cancer Treatment Import and Export
5.6 Japan Gallbladder Cancer Treatment Market Analysis
5.6.1 Japan Gallbladder Cancer Treatment Production
5.6.2 Japan Gallbladder Cancer Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Gallbladder Cancer Treatment Import and Export
5.7 Southeast Asia Gallbladder Cancer Treatment Market Analysis
5.7.1 Southeast Asia Gallbladder Cancer Treatment Production
5.7.2 Southeast Asia Gallbladder Cancer Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Gallbladder Cancer Treatment Import and Export
5.8 India Gallbladder Cancer Treatment Market Analysis
5.8.1 India Gallbladder Cancer Treatment Production
5.8.2 India Gallbladder Cancer Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Gallbladder Cancer Treatment Import and Export

6 Gallbladder Cancer Treatment Segment Market Analysis (by Type)
6.1 Global Gallbladder Cancer Treatment Production by Type
6.2 Global Gallbladder Cancer Treatment Revenue by Type
6.3 Gallbladder Cancer Treatment Price by Type

7 Gallbladder Cancer Treatment Segment Market Analysis (by Application)
7.1 Global Gallbladder Cancer Treatment Consumption by Application
7.2 Global Gallbladder Cancer Treatment Consumption Market Share by Application (2014-2019)

8 Gallbladder Cancer Treatment Major Manufacturers Analysis
8.1 4SC AG
8.1.1 4SC AG Gallbladder Cancer Treatment Production Sites and Area Served
8.1.2 4SC AG Product Introduction, Application and Specification
8.1.3 4SC AG Gallbladder Cancer Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Advenchen Laboratories LLC
8.2.1 Advenchen Laboratories LLC Gallbladder Cancer Treatment Production Sites and Area Served
8.2.2 Advenchen Laboratories LLC Product Introduction, Application and Specification
8.2.3 Advenchen Laboratories LLC Gallbladder Cancer Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Array BioPharma Inc
8.3.1 Array BioPharma Inc Gallbladder Cancer Treatment Production Sites and Area Served
8.3.2 Array BioPharma Inc Product Introduction, Application and Specification
8.3.3 Array BioPharma Inc Gallbladder Cancer Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Aslan Pharmaceuticals Pte Ltd
8.4.1 Aslan Pharmaceuticals Pte Ltd Gallbladder Cancer Treatment Production Sites and Area Served
8.4.2 Aslan Pharmaceuticals Pte Ltd Product Introduction, Application and Specification
8.4.3 Aslan Pharmaceuticals Pte Ltd Gallbladder Cancer Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Bayer AG
8.5.1 Bayer AG Gallbladder Cancer Treatment Production Sites and Area Served
8.5.2 Bayer AG Product Introduction, Application and Specification
8.5.3 Bayer AG Gallbladder Cancer Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 BeiGene Ltd
8.6.1 BeiGene Ltd Gallbladder Cancer Treatment Production Sites and Area Served
8.6.2 BeiGene Ltd Product Introduction, Application and Specification
8.6.3 BeiGene Ltd Gallbladder Cancer Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Eli Lilly and Co
8.7.1 Eli Lilly and Co Gallbladder Cancer Treatment Production Sites and Area Served
8.7.2 Eli Lilly and Co Product Introduction, Application and Specification
8.7.3 Eli Lilly and Co Gallbladder Cancer Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Halozyme Therapeutics Inc
8.8.1 Halozyme Therapeutics Inc Gallbladder Cancer Treatment Production Sites and Area Served
8.8.2 Halozyme Therapeutics Inc Product Introduction, Application and Specification
8.8.3 Halozyme Therapeutics Inc Gallbladder Cancer Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Hutchison MediPharma Ltd
8.9.1 Hutchison MediPharma Ltd Gallbladder Cancer Treatment Production Sites and Area Served
8.9.2 Hutchison MediPharma Ltd Product Introduction, Application and Specification
8.9.3 Hutchison MediPharma Ltd Gallbladder Cancer Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Ipsen SA
8.10.1 Ipsen SA Gallbladder Cancer Treatment Production Sites and Area Served
8.10.2 Ipsen SA Product Introduction, Application and Specification
8.10.3 Ipsen SA Gallbladder Cancer Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Kringle Pharma Inc
8.12 Leap Therapeutics Inc
8.13 MedImmune LLC
8.14 Molecular Templates Inc
8.15 Novartis AG
8.16 NuCana Plc
8.17 OncoTherapy Science Inc
8.18 VasGene Therapeutics Inc

9 Development Trend of Analysis of Gallbladder Cancer Treatment Market
9.1 Global Gallbladder Cancer Treatment Market Trend Analysis
9.1.1 Global Gallbladder Cancer Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Gallbladder Cancer Treatment Regional Market Trend
9.2.1 North America Gallbladder Cancer Treatment Forecast 2019-2025
9.2.2 Europe Gallbladder Cancer Treatment Forecast 2019-2025
9.2.3 China Gallbladder Cancer Treatment Forecast 2019-2025
9.2.4 Japan Gallbladder Cancer Treatment Forecast 2019-2025
9.2.5 Southeast Asia Gallbladder Cancer Treatment Forecast 2019-2025
9.2.6 India Gallbladder Cancer Treatment Forecast 2019-2025
9.3 Gallbladder Cancer Treatment Market Trend (Product Type)
9.4 Gallbladder Cancer Treatment Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Gallbladder Cancer Treatment Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Gallbladder Cancer Treatment
Table Global Gallbladder Cancer Treatment Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Gallbladder Cancer Treatment Production Market Share by Types in 2018
Figure Apatinib Mesylate Product Picture
Figure BGBA-317 Product Picture
Figure Binimetinib Product Picture
Figure Others Product Picture
Table Global Gallbladder Cancer Treatment Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Gallbladder Cancer Treatment Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global Gallbladder Cancer Treatment Revenue (Million USD) (2014-2025)
Figure Global Gallbladder Cancer Treatment Production (K Pcs) (2014-2025)
Figure North America Gallbladder Cancer Treatment Market Size (Million USD) (2014-2025)
Figure Europe Gallbladder Cancer Treatment Market Size (Million USD) (2014-2025)
Figure China Gallbladder Cancer Treatment Market Size (Million USD) (2014-2025)
Figure Japan Gallbladder Cancer Treatment Market Size (Million USD) (2014-2025)
Figure Southeast Asia Gallbladder Cancer Treatment Market Size (Million USD) (2014-2025)
Figure India Gallbladder Cancer Treatment Market Size (Million USD) (2014-2025)
Table Gallbladder Cancer Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Gallbladder Cancer Treatment in 2018
Figure Manufacturing Process Analysis of Gallbladder Cancer Treatment
Figure Industry Chain Structure of Gallbladder Cancer Treatment
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Gallbladder Cancer Treatment Manufacturing Plants Distribution
Table Gallbladder Cancer Treatment Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Gallbladder Cancer Treatment Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Gallbladder Cancer Treatment Production (K Pcs) of Major Manufacturers (2014-2019)
Table Gallbladder Cancer Treatment Production Market Share of Major Manufacturers (2014-2019)
Figure Gallbladder Cancer Treatment Production Share by Manufacturers in 2018
Table Gallbladder Cancer Treatment Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Gallbladder Cancer Treatment Revenue Market Share of Major Manufacturers (2014-2019)
Figure Gallbladder Cancer Treatment Revenue Share by Manufacturers in 2018
Table Gallbladder Cancer Treatment Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Gallbladder Cancer Treatment Production by Regions 2014-2019 (K Pcs)
Table Global Gallbladder Cancer Treatment Production Market Share by Regions 2014-2019
Figure Global Gallbladder Cancer Treatment Production Market Share by Regions in 2018
Table Global Gallbladder Cancer Treatment Revenue by Regions 2014-2019 (Million USD)
Table Global Gallbladder Cancer Treatment Revenue Market Share by Regions 2014-2019
Figure Global Gallbladder Cancer Treatment Revenue Market Share by Regions in 2018
Table Global Gallbladder Cancer Treatment Consumption by Regions 2014-2019 (K Pcs)
Table Global Gallbladder Cancer Treatment Consumption Market Share by Regions 2014-2019
Figure North America Gallbladder Cancer Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure North America Gallbladder Cancer Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table North America Gallbladder Cancer Treatment Production, Consumption Import and Export (K Pcs)
Figure Europe Gallbladder Cancer Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Gallbladder Cancer Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Gallbladder Cancer Treatment Production, Consumption Import and Export (K Pcs)
Figure China Gallbladder Cancer Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure China Gallbladder Cancer Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table China Gallbladder Cancer Treatment Production, Consumption Import and Export (K Pcs)
Figure Japan Gallbladder Cancer Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Gallbladder Cancer Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Gallbladder Cancer Treatment Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Gallbladder Cancer Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Gallbladder Cancer Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Gallbladder Cancer Treatment Production, Consumption Import and Export (K Pcs)
Figure India Gallbladder Cancer Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure India Gallbladder Cancer Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table India Gallbladder Cancer Treatment Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Gallbladder Cancer Treatment Market Share by Application (2014-2019)
Figure Global Value (Consumption) Gallbladder Cancer Treatment Market Share by Application (2014-2019)
Table 4SC AG Gallbladder Cancer Treatment Production Sites and Area Served
Table 4SC AG Gallbladder Cancer Treatment Product Introduction, Application and Specification
Table 4SC AG Gallbladder Cancer Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table 4SC AG Gallbladder Cancer Treatment Production Growth Rate (2014-2019)
Table 4SC AG Gallbladder Cancer Treatment Production Market Share (2014-2019)
Figure 4SC AG Gallbladder Cancer Treatment Revenue Market Share (2014-2019)
Table 4SC AG Gallbladder Cancer Treatment Main Business and Markets Served
Table Advenchen Laboratories LLC Gallbladder Cancer Treatment Production Sites and Area Served
Table Advenchen Laboratories LLC Gallbladder Cancer Treatment Product Introduction, Application and Specification
Table Advenchen Laboratories LLC Gallbladder Cancer Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Advenchen Laboratories LLC Gallbladder Cancer Treatment Production Growth Rate (2014-2019)
Table Advenchen Laboratories LLC Gallbladder Cancer Treatment Production Market Share (2014-2019)
Figure Advenchen Laboratories LLC Gallbladder Cancer Treatment Revenue Market Share (2014-2019)
Table Advenchen Laboratories LLC Gallbladder Cancer Treatment Main Business and Markets Served
Table Array BioPharma Inc Gallbladder Cancer Treatment Production Sites and Area Served
Table Array BioPharma Inc Gallbladder Cancer Treatment Product Introduction, Application and Specification
Table Array BioPharma Inc Gallbladder Cancer Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Array BioPharma Inc Gallbladder Cancer Treatment Production Growth Rate (2014-2019)
Table Array BioPharma Inc Gallbladder Cancer Treatment Production Market Share (2014-2019)
Figure Array BioPharma Inc Gallbladder Cancer Treatment Revenue Market Share (2014-2019)
Table Array BioPharma Inc Gallbladder Cancer Treatment Main Business and Markets Served
Table Aslan Pharmaceuticals Pte Ltd Gallbladder Cancer Treatment Production Sites and Area Served
Table Aslan Pharmaceuticals Pte Ltd Gallbladder Cancer Treatment Product Introduction, Application and Specification
Table Aslan Pharmaceuticals Pte Ltd Gallbladder Cancer Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Aslan Pharmaceuticals Pte Ltd Gallbladder Cancer Treatment Production Growth Rate (2014-2019)
Table Aslan Pharmaceuticals Pte Ltd Gallbladder Cancer Treatment Production Market Share (2014-2019)
Figure Aslan Pharmaceuticals Pte Ltd Gallbladder Cancer Treatment Revenue Market Share (2014-2019)
Table Aslan Pharmaceuticals Pte Ltd Gallbladder Cancer Treatment Main Business and Markets Served
Table Bayer AG Gallbladder Cancer Treatment Production Sites and Area Served
Table Bayer AG Gallbladder Cancer Treatment Product Introduction, Application and Specification
Table Bayer AG Gallbladder Cancer Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bayer AG Gallbladder Cancer Treatment Production Growth Rate (2014-2019)
Table Bayer AG Gallbladder Cancer Treatment Production Market Share (2014-2019)
Figure Bayer AG Gallbladder Cancer Treatment Revenue Market Share (2014-2019)
Table Bayer AG Gallbladder Cancer Treatment Main Business and Markets Served
Table BeiGene Ltd Gallbladder Cancer Treatment Production Sites and Area Served
Table BeiGene Ltd Gallbladder Cancer Treatment Product Introduction, Application and Specification
Table BeiGene Ltd Gallbladder Cancer Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table BeiGene Ltd Gallbladder Cancer Treatment Production Growth Rate (2014-2019)
Table BeiGene Ltd Gallbladder Cancer Treatment Production Market Share (2014-2019)
Figure BeiGene Ltd Gallbladder Cancer Treatment Revenue Market Share (2014-2019)
Table BeiGene Ltd Gallbladder Cancer Treatment Main Business and Markets Served
Table Eli Lilly and Co Gallbladder Cancer Treatment Production Sites and Area Served
Table Eli Lilly and Co Gallbladder Cancer Treatment Product Introduction, Application and Specification
Table Eli Lilly and Co Gallbladder Cancer Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly and Co Gallbladder Cancer Treatment Production Growth Rate (2014-2019)
Table Eli Lilly and Co Gallbladder Cancer Treatment Production Market Share (2014-2019)
Figure Eli Lilly and Co Gallbladder Cancer Treatment Revenue Market Share (2014-2019)
Table Eli Lilly and Co Gallbladder Cancer Treatment Main Business and Markets Served
Table Halozyme Therapeutics Inc Gallbladder Cancer Treatment Production Sites and Area Served
Table Halozyme Therapeutics Inc Gallbladder Cancer Treatment Product Introduction, Application and Specification
Table Halozyme Therapeutics Inc Gallbladder Cancer Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Halozyme Therapeutics Inc Gallbladder Cancer Treatment Production Growth Rate (2014-2019)
Table Halozyme Therapeutics Inc Gallbladder Cancer Treatment Production Market Share (2014-2019)
Figure Halozyme Therapeutics Inc Gallbladder Cancer Treatment Revenue Market Share (2014-2019)
Table Halozyme Therapeutics Inc Gallbladder Cancer Treatment Main Business and Markets Served
Table Hutchison MediPharma Ltd Gallbladder Cancer Treatment Production Sites and Area Served
Table Hutchison MediPharma Ltd Gallbladder Cancer Treatment Product Introduction, Application and Specification
Table Hutchison MediPharma Ltd Gallbladder Cancer Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Hutchison MediPharma Ltd Gallbladder Cancer Treatment Production Growth Rate (2014-2019)
Table Hutchison MediPharma Ltd Gallbladder Cancer Treatment Production Market Share (2014-2019)
Figure Hutchison MediPharma Ltd Gallbladder Cancer Treatment Revenue Market Share (2014-2019)
Table Hutchison MediPharma Ltd Gallbladder Cancer Treatment Main Business and Markets Served
Table Ipsen SA Gallbladder Cancer Treatment Production Sites and Area Served
Table Ipsen SA Gallbladder Cancer Treatment Product Introduction, Application and Specification
Table Ipsen SA Gallbladder Cancer Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ipsen SA Gallbladder Cancer Treatment Production Growth Rate (2014-2019)
Table Ipsen SA Gallbladder Cancer Treatment Production Market Share (2014-2019)
Figure Ipsen SA Gallbladder Cancer Treatment Revenue Market Share (2014-2019)
Table Ipsen SA Gallbladder Cancer Treatment Main Business and Markets Served
Table Kringle Pharma Inc Gallbladder Cancer Treatment Production Sites and Area Served
Table Leap Therapeutics Inc Gallbladder Cancer Treatment Production Sites and Area Served
Table MedImmune LLC Gallbladder Cancer Treatment Production Sites and Area Served
Table Molecular Templates Inc Gallbladder Cancer Treatment Production Sites and Area Served
Table Novartis AG Gallbladder Cancer Treatment Production Sites and Area Served
Table NuCana Plc Gallbladder Cancer Treatment Production Sites and Area Served
Table OncoTherapy Science Inc Gallbladder Cancer Treatment Production Sites and Area Served
Table VasGene Therapeutics Inc Gallbladder Cancer Treatment Production Sites and Area Served
Figure Global Gallbladder Cancer Treatment Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Gallbladder Cancer Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Gallbladder Cancer Treatment Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Gallbladder Cancer Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Gallbladder Cancer Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Gallbladder Cancer Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Gallbladder Cancer Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Gallbladder Cancer Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Gallbladder Cancer Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Gallbladder Cancer Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Gallbladder Cancer Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Gallbladder Cancer Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Gallbladder Cancer Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Gallbladder Cancer Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Gallbladder Cancer Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Gallbladder Cancer Treatment by Type (2019-2025)
Table Global Consumption (K Pcs) of Gallbladder Cancer Treatment by Application (2019-2025)
Table Gallbladder Cancer Treatment Distributors List
Table Gallbladder Cancer Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

4SC AG、Advenchen Laboratories LLC、Array BioPharma Inc、Aslan Pharmaceuticals Pte Ltd、Bayer AG、BeiGene Ltd、Eli Lilly and Co、Halozyme Therapeutics Inc、Hutchison MediPharma Ltd、Ipsen SA、Kringle Pharma Inc、Leap Therapeutics Inc、MedImmune LLC、Molecular Templates Inc、Novartis AG、NuCana Plc、OncoTherapy Science Inc、VasGene Therapeutics Inc、

★調査レポート[世界の胆嚢癌治療市場 2019年] (コード：DATA909X08283)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の胆嚢癌治療市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 胆嚢癌療法の世界市場：規模・現状・予測2019-2025
    DATA909X18497 / QYResearch / 2019年11月25日 / ※当調査レポートでは、胆嚢癌療法の世界市場について調査・分析し、胆嚢癌療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（併用療法、単剤療法）、用途別（病院、医学研究所、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の胆嚢癌療法市場動向 ・主要企業別マーケットシェア ・胆嚢癌療法の種類別市場規模2014-2019 （併用療法、単剤療法） ・胆嚢癌療法の用途別市場規模2014-2019 （病院、医学研究所、クリニック、その他） ・胆嚢癌療法の北米市場：主要企業・種類別/用途別市場規模 ・胆嚢癌療法のヨーロッパ市場：主要企業・種類別/用途別市場規模...Rising incidence of cholelithiasis, chronic inflammation of the gallbladder, and gallbladder polyps are contributing to the prevalence of gallbladder cancer. This has resulted in a rise in demand for therapeutics for treating the condition.Surgery is considered the primary treatment approach for gallbladder cancer, which involves the complete removal of the organ. However, the second line of treatment involves the use of radiation therapy along with chemotherapeutics. The rising availability of financial assistance programs is further helping patients in availing these high-cost treatments. With the increasing occurrence of these risk factors, the need for gallbladder cancer therapeutics will subsequently increase over...
  • 世界の下咽頭癌治療市場 2019年
    DATA909X09521 / QYResearch / 2019年11月20日 / ※本調査レポートは、下咽頭癌治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ガネテスピブ、PGV-001、ニモツズマブ、CDX-3379、その他に、用途別には、外来患者、入院患者にセグメント区分し、下咽頭癌治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・下咽頭癌治療の世界市場概要 ・下咽頭癌治療の製造コスト構成分析 ・下咽頭癌治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・下咽頭癌治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・下咽頭癌治療のセグメント分析（種類別） （ガネテスピブ、PGV-001、ニモツズマブ、CDX-3379、その他）...The global Hypopharyngeal Cancer Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hypopharyngeal Cancer Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypopharyngeal Cancer Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hypopharyngeal Cancer Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のトリプルネガティブ乳癌治療市場 2019年
    DATA909X16858 / QYResearch / 2019年11月22日 / ※本調査レポートは、トリプルネガティブ乳癌治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アルキル化剤、植物製品、微生物製品、代謝拮抗剤、微小管安定剤に、用途別には、病院薬局、小売薬局にセグメント区分し、トリプルネガティブ乳癌治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・トリプルネガティブ乳癌治療の世界市場概要 ・トリプルネガティブ乳癌治療の製造コスト構成分析 ・トリプルネガティブ乳癌治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・トリプルネガティブ乳癌治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・トリプルネガティブ乳癌治療のセグメント分析（種類別） （アルキル化剤、植物製品、微生物製品、代謝拮抗剤、微小管安定剤）...The global Triple-Negative Breast Cancer Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Triple-Negative Breast Cancer Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Triple-Negative Breast Cancer Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Triple-Negative Breast Cancer Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

    • ◆H&Iグローバルリサーチのお客様（例）◆